News

GSK (NYSE:GSK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Blenrep as a late-line option and as part ...
A month after the FDA lifted its clinical hold on GSK’s vaginal yeast infection drug Brexafemme (ibrexafungerp), the developer of the treatment, Scynexis, has resumed a phase 3 study in another use.
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) and GSK plc (LSE/NYSE: GSK), today announced that the pivotal Phase 3 PIVOT-PO trial evaluating tebipenem ...
Alyson Hannigan, Ask2BSure spokesperson, actress, and mom, stars in an Ask2BSure campaign video to raise awareness about meningitis and vaccination amongst parents of teens and young adults.
The U.S. Food and Drug Administration has approved GSK plc (NYSE:GSK)’s asthma medication, Nucala, for expanded use in treating a form of chronic obstructive pulmonary disease (COPD), often ...
GSK GSK2.07%increase; green up pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British ...
advising those who are adamant about trying this bizarre trend to be “especially careful not to choose a hemorrhoid cream with hydrocortisone in it, as that’s a topical steroid that will thin ...
The FDA has lifted its 19-month clinical hold on vaginal yeast infection drug Brexafemme (ibrexafungerp), according to the treatment's developer Scynexis. In its first-quarter report, the Jersey ...
A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval, positioning the biologic medicine to reach ...
(RTTNews) - GSK plc. (GSK, GSK.L) announced that the US Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately ...
Supplements containing butyrate have become significantly more popular over recent years because of the potential health benefits they offer. Butyrate, a short-chain fatty acid, is created by gut ...